Position in ADMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,368,359
-$1,004,864 QoQ
Shares Held
880,330
-5.3% QoQ
Ownership
0.393%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 323 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 4%
Shared 28%
None 69%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. ADMA ranks #25 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in ADMA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,368,359 | 880,330 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,373,223 | 929,326 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,088,796 | 169,342 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,609,743 | 1,405,849 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,809,456 | 703,430 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $1,902,355 | 95,885 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $773,188 | 45,084 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,507,041 | 225,465 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $313,273 | 28,021 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $70,322 | 10,655 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $267,862 | 59,262 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $110,682 | 30,917 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $99,425 | 26,945 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $39,047 | 11,797 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $92,256 | 23,778 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $19,232 | 7,915 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,162 | 6,648 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $97,507 | 53,283 | Shares | Defined | 2022-05-16 | |
| 2021-09-30 | $4,740 | 4,195 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,675 | 7,297 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $18,480 | 10,500 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $23,526 | 12,065 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $12,817 | 5,363 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $13,468 | 4,597 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $21,846 | 7,586 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||